Skip to main content
Premium Trial:

Request an Annual Quote

EU Clears Prodesse’s H1N1 Test

NEW YORK (GenomeWeb News) – Prodesse’s molecular diagnostic test for H1N1 swine flu infections has been cleared by EU regulators for commercialization in Europe.

The firm, which recently became a subsidiary of Gen-Probe, received the CE Mark clearance for its ProFlu-ST assay as a diagnostic to differentiate among influenza strains.

The RT-PCR-based test detects and identifies the 2009 H1N1 virus, the seasonal influenza A/H1 virus, and the seasonal A/H3 virus.

Because these three influenza A subtypes have different susceptibilities to antiviral drugs, identifying the strain can help doctors treat patients appropriately.

Prodesse said it expects that the ProFlu-ST assay will be used in conjunction with its ProFlu+ assay, which detects influenza A and B and respiratory syncytial virus, and received CE mark in 2007.

The US Food and Drug Administration last month granted an emergency use authorization for Prodesse’s ProFlu-ST assay in the CLIA labs in the US, but it has not granted approval to 2009 H1N1 tests for the virus.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.